When we want to diagnose a disease or monitor an organ's health, our default clinical approach is to draw blood or collect a peripheral biofluid. Blood is highly accessible, continuously circulates, and interacts with nearly every tissue in the body. However, treating systemic biofluids as a perfect mirror for localized tissue environments introduces a fundamental diagnostic error.
The molecular and metabolic landscape inside a specific organ, joint, or tumor microenvironment is often entirely decoupled from what we measure in peripheral circulation. This phenomenon—systemic-local biomarker divergence—occurs because of distinct physical, chemical, and biological mechanisms that alter, dilute, or completely block molecular signals as they travel from a local lesion to the systemic pool. Understanding why these environments diverge is critical to building more accurate diagnostic models.
Dilution, Degradation, and Barriers to Release
The most intuitive reason a local tissue state fails to reflect in the blood is the sheer effect of dilution and localized degradation. A small, localized cluster of diseased cells releases signaling molecules into the surrounding interstitial fluid, but by the time those molecules cross endothelial barriers and mix with liters of systemic blood, their concentration drops below detectable thresholds.
Furthermore, molecules are often degraded before they can ever escape the local microenvironment. As single-author Bing He notes in an evaluation of circulating long noncoding RNAs (Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty), a profound discrepancy exists between a biomarker's concentration within a tumor and its presence in the bloodstream. This attenuation is driven by localized enzymatic degradation or inefficient active release mechanisms into the vasculature.
Because of this barrier to entry, systemic blood tests can act as poor proxies for intra-tumoral biology. For instance, Oosting et al. used molecular imaging (89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment) to demonstrate that circulating plasma levels of target proteins fail to correlate with local tumor concentrations. Consequently, relying solely on plasma biomarkers can completely obscure whether a drug is successfully engaging its target at the actual disease site.
Compartmental Isolation and Anatomical Barriers
Many of the body's most critical organs are protected by strict anatomical barriers that isolate their local fluids from general circulation. The blood-brain barrier, the blood-retinal barrier, and the blood-follicle barrier create distinct, self-contained microenvironments.
In ophthalmology, for example, Hu et al. found that measuring hypoxia markers in the aqueous humor (Expressions of HIF-1α and MiR-210 in aqueous humor of patients with central retinal vein occlusion combined with macular edema) does not accurately represent the molecular concentrations present in deeper ocular structures like the retinal tissue or vitreous cavity.
A similar challenge appears in reproductive biology. Yu et al. demonstrated that utilizing peripheral blood to study premature ovarian insufficiency (Exploring biomarkers of premature ovarian insufficiency based on oxford nanopore transcriptional profile and machine learning) introduces a significant proxy discrepancy. The systemic circulation fails to reflect the highly specialized, localized molecular environment of follicular fluid or granulosa cells, masking the true mechanisms of organ failure.
Conversely, when a biomarker is elevated in a local fluid compartment, it does not automatically mean the signal originated there. Passive diffusion can work in reverse. Trapé et al. showed that high concentrations of tumor markers in ascitic fluid often result from passive diffusion from the bloodstream rather than local production by a primary lesion (Comparative Assessment of Two Strategies for Interpreting Tumor Markers in Ascitic Effusions). To resolve this, the authors utilized a fluid-to-serum ratio, effectively filtering out systemic "noise" to isolate the true localized pathological signal.
Localized Enzymatic Activity and Paracrine Signaling
Divergence is not merely a passive consequence of physical barriers; it is actively driven by localized metabolic and enzymatic processes that alter molecular behavior at the tissue level.
Hormones and growth factors frequently exist in bound (inactive) and free (bioactive) states, regulated by local enzymes. Cheng et al. investigated this dynamic in prostate cancer (Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutrition). They discovered that while total systemic levels of insulin-like growth factor-I (IGF-I) correlate with cancer risk, the circulating free fraction shows no association. This occurs because localized enzymatic activity within the tumor microenvironment alters the availability of growth factors locally, meaning that blood-based measurements fail to reflect the biological reality at the tissue level.
Furthermore, many signaling molecules are designed to act strictly as paracrine or autocrine agents, functioning entirely within a local cellular network. Single-author Lai identified a stark disconnect between local tissue expression and systemic circulating levels of zinc alpha-2-glycoprotein (ZAG) in dialysis patients (Adipose and serum zinc alpha-2-glycoprotein (ZAG) expressions predict longitudinal change of adiposity, wasting and predict survival in dialysis patients). Because certain adipokines function through distinct paracrine and endocrine pathways simultaneously, systemic blood measurements can completely miss or misrepresent the localized metabolic activity occurring within specific fat depots.
Excretion Dynamics vs. Internal Storage
When researchers attempt to use non-invasive peripheral biofluids like sweat or urine as systemic proxies, the divergence becomes even more pronounced. This is because these fluids are governed by active excretion dynamics rather than internal homeostasis or storage levels.
As reviewed by Balch et al. (Towards an Accessible, Noninvasive Micronutrient Status Assessment Method: A Comprehensive Review of Existing Techniques), biomarker concentrations in sweat often correlate poorly with systemic nutrient levels or internal storage. Many non-invasive markers reflect immediate excretion processes and localized sweat gland metabolism rather than providing a stable proxy for overall physiological status. A spike in a sweat-based marker may indicate that the body is actively discarding a substance, completely inverting the trend of what is being retained in internal tissue storage.
Bridging the Gap
Recognizing why systemic and local biomarkers diverge changes how we interpret clinical data. Relying on whole blood or plasma without accounting for dilution, local degradation, compartmental barriers, or paracrine signaling pathways creates profound diagnostic blind spots.
To build truly predictive models, modern molecular diagnostics must move away from treating the bloodstream as a homogenous reflection of the body. Instead, researchers are increasingly integrating systemic profiles with site-specific imaging, fluid-to-serum ratios, and direct tissue transcriptomics to map the complex pathways connecting local pathology to systemic circulation.
Key Foundational Work
Time Course of Free Radical Production After Primary Coronary Angioplasty for Acute Myocardial Infarction and the Effect of Vitamin C (1999) — contributed 1 concept elements to this direction.
Variable Thyrotropin Response to Thyrotropin-releasing Hormone after Small Decreases in Plasma Free Thyroid Hormone Concentrations in Patients with Nonthyroidal Diseases (1980) — contributed 1 concept elements to this direction.
Low calcium dialysis administration in four cases of hypercalcemia with malignant disease concomitant with renal failure. (1999) — contributed 1 concept elements to this direction.